Facilitation of Development of Resistance to Morphine Analgesia by Desglycinamide9-Lysine Vasopressin
AUTOR(ES)
Krivoy, William A.
RESUMO
Desglycinamide9-lysine vasopressin facilitates development of resistance to the analgesic action of morphine in mice if morphine is administered before the peptide. Desglycinamide9-lysine vasopressin is not a morphine antagonist, and does not appear to cause either hyperalgesia or alteration of the response to the technique used for evaluating analgesia.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=388340Documentos Relacionados
- Effect of Corticotropin and Desglycinamide9-Lysine Vasopressin on Suppression of Memory by Puromycin
- Inactivation of lysine-vasopressin by acetone.
- Epidural morphine analgesia in Guillain Barré syndrome.
- Peptide inhibitor of morphine- and beta-endorphin-induced analgesia.
- No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.
